Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C86 - Dopaminergic Therapy for Motor Symptoms in Early Parkinson's Disease

Monday 04/24/23
11:15 AM - 12:15 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Tamara M. Pringsheim, MD, FAAN
Movement Disorders
Participants will become familar with the AAN Practice Parameter: Initiation of Dopaminergic Therapy for Motor Symptoms in Early PD; when to initiate pharmacological therapy for motor symptoms in early Parkinson's disease; with what to initiate therapy for motor symptoms in early Parkinson's disease; and how to monitor dopaminergic therapy for motor symptoms in early Parkinson's disease.

This program is supported in part by an educational grant from Cerevel Therapeutics

The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.
1.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge
Introductory
Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
11:15 AM - 11:25 AM EST Introduction Dopaminergic Therapy for Motor Symptoms in Early Parkinson's disease
Tamara M. Pringsheim, MD, FAAN
11:25 AM - 11:40 AM EST Speaker Case 1
Robertus Maria Alfonsius De Bie, MD
11:40 AM - 11:55 AM EST Speaker Case 2
Robertus Maria Alfonsius De Bie, MD
11:55 AM - 12:10 PM EST Speaker Case 3
Tamara M. Pringsheim, MD, FAAN
12:10 PM - 12:15 PM EST Closing Remarks Summary Recommendations
Tamara M. Pringsheim, MD, FAAN
Faculty Disclosures
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Robertus Maria Alfonsius De Bie, MD No disclosure on file